Hemangioma and Arteriovenous Malformation: Percutaneous Sclerotherapy and Endovascular Treatment
- Author:
Dae Hyun HWANG
1
;
Jin Wook CHUNG
;
Jae Hyung PARK
Author Information
1. Department of Radiology, Hallym University Medical College, Korea.
- Publication Type:Original Article
- Keywords:
Hemangioma;
Arteriovenous malformation;
Sclerotherapy;
Endovascular
- MeSH:
Arteriovenous Malformations;
Ethanol;
Hemangioma;
Humans;
Sclerotherapy
- From:Journal of the Korean Society for Vascular Surgery
1998;14(1):51-57
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: This study was done to evaluate the efficacy and safety of percutaneous sclerotherapy or endovascular treatment of hemangioma and venous malformation. METHODS: 9 interventional procedures were performed in 7 patients whose age ranged from 16 years to 52 years. Five of these patients had arteriovenous malformation, the remaining had hemangioma and venous malformation. N-buty1-2-cyanoacrylate was injected percutaneously in 4 procedures and intraarterially in one procedure. Ethanol with lipiodol(10%) was injected percutaneously in 2 procedures. 1valon particle was embolized intraarterial in 1 procedure. RESULTS: N-buty1-2-cyanoacrylate injection, Contour arterial embolozation, Etanole with lipiodo1, sclerotherapy followed by physician and was judged beneficial in 7 of 7 patients. One pateint had minor complication(skin ulcer) but no long term sequelae. CONCLUSIONS: Percutaneous sclerotherapy and endovascular treatment, either or before surgery is a safe and effective method of managing hemangioma and arteriovenous malformations.
